logo
  

SQI Diagnostics : FDA Stops EUA Review Of RALI-Dx IL-6 Severity Triage Test For COVID-19 Patients

SQI Diagnostics Inc.(SQD.V, SQIDF), a Canadian precision medicine company that develops rapid diagnostic testing, said that U.S. Food and Drug Administration will not continue its review of the company's submission of the RALI-Dx IL-6 Severity Triage Test for Emergency Use Authorization under the "Tests for Management of COVID-19 Patients" category.

The FDA cites a high volume of EUA requests and its prioritization of EUA reviews according to factors including the public health need for the product and shortages of critical devices during the pandemic.

However, the FDA has asked SQI to submit an application under a non-EUA regulatory pathway.

The RALI-Dx IL-6 Severity Triage Test has broad applicability in helping to identify patients with severe inflammatory response arising from COVID-19 and other causes of respiratory distress.

SQI said it is confident that the FDA prioritization will support its upcoming COVID-19 HOME Antibody Test submission under the EUA regulatory pathway.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
McDonald's says equal pay for women is just the beginning, while conforming that the fast-food giant pays women globally 99.85 cents on the dollar for similar work, taking into account legitimate pay drivers such as level, location, experience, and performance. The company added that it is on track to close that identified gap in 2022. Verizon Communications Inc. (VZ) said, on an adjusted basis, its third-quarter earnings per share rose 12.8 percent from a year ago. The company said its earnings were highlighted by revenue and customer growth as more than one in four Consumer wireless phone customers now have a 5G-capable device. The... While reporting financial results for the third quarter on Wednesday, Abbott Laboratories (ABT) raised its earnings and adjusted earnings guidance for the full-year 2021. For fiscal 2021, the company continues to project earnings from continuing operations in a range of $3.55 to $3.6 per share and...
RELATED NEWS
Follow RTT